Follow the GENETIC SIGNATURES LIMITED share price and the full directors' dealings record of the company, a listed equity based in Australia. Shares are listed on the AU market, under the oversight of ASX. Market capitalisation: €21.6m. The latest transaction was filed on 1 September 2026 (Other). Among the most active insiders: Caroline Waldron. All data is openly available.
6
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 26,437 of 29,063 companies
20.8
score / 100
Value
2
Quality
39
FCF yld-61%
Earn yld-93%
EV/EBITDA·
ROE-33%
Gross mgn49%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
GENETIC SIGNATURES LIMITED es una empresa que cotiza en la Bolsa de Valores de Australia, especializada en el desarrollo de pruebas de diagnóstico basadas en tecnología de ADN. Se centra en la detección rápida y precisa de patógenos en muestras clínicas.